e association of neuropathic pain and disease activity, functional level, and quality of life in patients with ankylosing spondylitis: a cross-sectional study

doi:10.3906/sag-1707-147

Cited by 16 publications

(11 citation statements)

References 36 publications

(50 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previous studies, either in RA or SpA, showed that high painDETECT scores were generally not associated with greater inflammation (C-reactive protein and erythrocyte sedimentation rate) but strongly correlated with the patients' global assessment. 14 This was also true for our cohort ( P = 0.000).…”

Section: Discussionsupporting

confidence: 74%

Are painDETECT scores in musculoskeletal disorders associated with duration of daily pain and time elapsed since current pain onset?

Berthelot¹,

Biha²,

Darrieutort-Laffite³

et al. 2019

PR9

View full text Add to dashboard Cite

Objectives:We aimed to compare painDETECT scores in outpatients seen in a rheumatology department over a 1-month period and search for correlations between painDETECT scores and the estimated duration of daily pain and time elapsed since the onset of current pain.Patients and Methods:A total of 529 of 738 outpatients agreed to complete a set of questionnaires, including painDETECT.Results:The mean painDETECT score was 14.14 ± 7.59, and 31% of the patients had painDETECT scores of >18. Fibromyalgia ranked first (21.2 ± 6.0), followed by osteoarthritis of the lower limbs (17.8 ± 8.2), back pain and radiculopathies (16.1 ± 6.8), osteoarthritis of the upper limbs (15.7 ± 8.1), spondylarthrosis (15.1 ± 7.2), entrapment neuropathies (14.1 ± 2.4), rheumatoid arthritis (13.8 ± 7.1), miscellaneous conditions (13.8 ± 8.2), tendinitis (13.4 ± 7.9), connectivitis (11.5 ± 6.7), and osteoporosis (8.5 ± 6.9). The duration of daily pain was much longer in patients with painDETECT scores of >18 (12.41 ± 8.45 vs 6.53 ± 7.45 hours) (t = 0.0000), but very similar painDETECT scores were observed for patients suffering from pain for less than 1 week (13.7 ± 8.2; 38% > 18), for 1 month (14.5 ± 8.2; 25% > 18), several months (12.7 ± 7.3; 23% > 18), 1 year (13.8 ± 7.7; 29% > 18), or several years (14.7 ± 7.4; 33% > 18).Conclusion:PainDETECT scores differed little depending on the musculoskeletal condition, strongly correlated with the duration of daily pain, and appeared to be as high in patients with recent pain as in those suffering for years.

show abstract

Section: Discussionsupporting

confidence: 74%

Are painDETECT scores in musculoskeletal disorders associated with duration of daily pain and time elapsed since current pain onset?

Berthelot¹,

Biha²,

Darrieutort-Laffite³

et al. 2019

PR9

View full text Add to dashboard Cite

show abstract

“…The present study showed that 23.4% of the patients with axSpA had NP, which is slightly higher than previous studies. [ 12 , 13 , 15 ] Patients with no pain relief reported higher rates of NP, and the presence of NP predicts poor pain relief in axSpA patients treated with NSAIDs. Of note, NSAIDs reduce the sensitivity of local pain receptors to inflammatory substances by blocking cyclooxygenase, interfering with prostaglandin synthesis.…”

Section: Discussionmentioning

confidence: 99%

Association between clinical characteristics and pain relief in patients with axial spondyloarthritis treated with non-steroidal anti-inflammatory drugs

Deng¹,

He²,

Deng³

et al. 2020

Arch Rheumatol

View full text Add to dashboard Cite

Objectives: The aim of this study was to evaluate pain relief in axial spondyloarthritis (axSpA) patients treated with non-steroidal anti-inflammatory drugs (NSAIDs) and to investigate the relation of the demographic, clinical, and psychological characteristics with pain relief. Patients and methods: Between February 2017 and December 2019, a total of 94 patients (61 males, 33 females; mean age: 28.3±8.1 years; range, 14 to 54 years) who were diagnosed with axSpA and treated with NSAIDs were included. The patients were assessed at baseline and at three months. A reduction of 30% in the Numeric Rating Scale (NRS) indicates a clinically meaningful improvement. The patients were divided into the relief group (≥30% improvement in NRS) and non-relief group (<30% improvement). Potential influential factors for pain relief such as neuropathic pain (NP), disease activity, function, pain catastrophizing, and pain self-efficacy were assessed. The relationship between patients’ characteristics and pain relief was analyzed. Results: Seventy-two (76.6%) patients achieved pain relief. These patients had significantly higher baseline erythrocyte sedimentation rate, C-reactive protein, and lower percentage of NP. There was no significant difference between the two groups in function, pain catastrophizing, and pain self-efficacy. Multiple logistic regression analysis revealed that patients with NP were less likely to achieve pain relief (odds ratio [OR]: 3.531, 95% confidence interval [CI]: 1.155-10.789; p=0.027). Conclusion: Pain relief is still insufficient in some axSpA patients, despite the administration of NSAIDs. The presence of NP is significantly associated with poor pain relief. Alternative medications instead of NSAIDs are needed to achieve optimal pain relief, when NP is diagnosed.

show abstract

“…This form was designed by the researchers based on the relevant literature. Items consisted of questions about demographic characteristics and physical, social, and psychological effects associated with AS (age, sex, marital status, education level, employment, reason for not working, regular health control, medication, exercise, patient expression about physical status, social life, psychological state, and sexual life; Duruöz et al, 2013; Geler-Külcü et al, 2018; Hamilton-West & Quine, 2009; Kotsis et al, 2014; Lu et al, 2019).…”

Section: Methodsmentioning

confidence: 99%

The Quality of Life in Muslim Patients With Ankylosing Spondylitis in Türkiye

et al. 2023

View full text Add to dashboard Cite

Introduction: Successful approaches to managing physical and psychosocial impacts on quality of life (QoL) of people with ankylosing spondylitis (AS) are grounded in their sociocultural and religious perspectives. The purpose of this study was to assess the QoL of Muslim patients with AS in Türkiye. Methodology: This descriptive, cross-sectional study was conducted in 101 patients. The data were collected using a Demographic Form and the Ankylosing Spondylitis Quality of Life Index. Results: It was determined that the QoL of those who use medication regularly and whose physical activity, psychological state, social and sexual life are affected is statistically significantly worse ( p < .05). Discussion: Results can provide better understanding of the QoL of Muslim patients and physical, social, and psychological influences of AS on QoL in this population. These results may have substantial impact on designing interventions to improve the QoL of Muslim patients with AS and the factors affecting it.

show abstract

e association of neuropathic pain and disease activity, functional level, and quality of life in patients with ankylosing spondylitis: a cross-sectional study

Cited by 16 publications

References 36 publications

Are painDETECT scores in musculoskeletal disorders associated with duration of daily pain and time elapsed since current pain onset?

Are painDETECT scores in musculoskeletal disorders associated with duration of daily pain and time elapsed since current pain onset?

Association between clinical characteristics and pain relief in patients with axial spondyloarthritis treated with non-steroidal anti-inflammatory drugs

The Quality of Life in Muslim Patients With Ankylosing Spondylitis in Türkiye

Contact Info

Product

Resources

About